ITGB1 antibody (PerCP)
Quick Overview for ITGB1 antibody (PerCP) (ABIN7457665)
Target
See all ITGB1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
-
Comment
-
Matching Isotype Control: PerCP Mouse IgG1, κ Isotype Control (ABIN7469763)
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS with 0.05 % Proclin300, 1 % BSA
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store at 2~8°C and protected from prolonged exposure to light. Do not freeze.
-
-
- ITGB1 (Integrin beta 1 (ITGB1))
-
Alternative Name
- CD29
-
Background
- Integrin beta-1,ITB1,Itgb1,Fibronectin receptor subunit beta,VLA-4 subunit beta,CD29,CD29 is a 130 kD single chain type I glycoprotein also known as integrin β1, VLA-β chain, or gpIIa. It is broadly expressed on a majority of hematopoietic and non-hematopoietic cells, including leukocytes (although at low level on granulocytes), platelets, fibroblasts, endothelial cells, epithelial cells, and mast cells. CD29 is a member of the integrin family. It is non-covalently associated with integrin α1-α6 chains to form VLA-1 to VLA-6 Molecules, respectively. Integrins, which include CD29, bind to several cell surface (e.g. VCAM-1, MadCAM-1) and extracellular matrix molecules. CD29 acts as a fibronectin receptor and is involved in a variety of cell-cell and cell-matrix interactions.
-
Gene ID
- 3688
-
UniProt
- P05556
-
Pathways
- Cell-Cell Junction Organization, Regulation of G-Protein Coupled Receptor Protein Signaling, CXCR4-mediated Signaling Events, Signaling of Hepatocyte Growth Factor Receptor, Integrin Complex, SARS-CoV-2 Protein Interactome
Target
-